Načítá se...
Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models
Duchenne muscular dystrophy (DMD) is a devastating disease caused by mutations in dystrophin that compromise sarcolemma integrity. Currently, there is no treatment for DMD. Mutations in transient receptor potential mucolipin 1 (ML1), a lysosomal Ca(2+) channel required for lysosomal exocytosis, prod...
Uloženo v:
| Vydáno v: | Sci Adv |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Association for the Advancement of Science
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7032923/ https://ncbi.nlm.nih.gov/pubmed/32128386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aaz2736 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|